Close Menu

The story has been updated to include comments from the company's conference call.

NEW YORK – Bio-Techne said on Tuesday morning that its total fiscal fourth quarter sales declined 8 percent year over year while its Diagnostics and Genomics segment was essentially flat.

For the three months ended June 30, the Minneapolis-based company reported sales of $175.8 million, down from $191.7 million a year ago. It beat the consensus Wall Street estimate of $163.9 million. Organically, sales in Q4 2020 also declined 8 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.